CATALYST PHARMACEUTICALS, INC. - Director's Dealing 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CATALYST PHARMACEUTICALS, INC. (CPRX)
CIK: 0001369568
Period of Report: 2024-11-27

Reporting Person: INGENITO GARY (Chief Med. & Reg. Officer)

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-11-27	Common stock, par value $0.001 per share	M	12000	$4.01	Acquired	63391	Direct
2024-11-27	Common stock, par value $0.001 per share	S	8631	$22.74	Disposed	54760	Direct
2024-11-27	Common stock, par value $0.001 per share	S	3369	$22.673	Disposed	51391	Direct

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-11-27	Options to purchase common stock	$4.01	M	12000	Disposed	2025-01-02	Common Stock (12000)	Direct

F1: Shares were sold on the open market for personal reasons and not as a result of any disagreement with the Company.

F2: Options vested in three annual tranches beginning on January 2, 2019.